Neeraj Agarwal, MD, professor of medicine at the University of Utah and one of the world authorities on prostate cancer and GU oncology visits with me on the podcast. He discusses management decisions for patients with advanced or metastatic prostate cancer, including weariness in using ADT for many patients with co-morbidities and how clinicians are currently weighing existing regimens.
No one knows prostate cancer more than Neeraj; I always learn from him and I am one of his biggest fans.
Dr Nabhan and the podcast guests have no relevant financial disclosures.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Pedro Barata, Director of the Clinical Genitourinary Medical Oncology Research Program at UH Seidman Cancer Center, provides an exclusive round-up of the most groundbreaking and practice-changing research unveiled at the ASCO GU 2024 meeting. With expertise and insight, he delves into pivotal studies such as CheckMate 914 Part B and KEYNOTE-564, exploring their implications
Dr. LaBelle elucidates the complexities of sickle cell disease, unraveling the devastating impact it has on individuals. The episode delves into various treatments and approaches to combat this formidable disease, including bone marrow transplant and the groundbreaking use of CRISPR-Cas9 technology. LaBelle shares insights into the recent research breakthroughs, citing the remarkable research report published
n this poignant episode, USA Today investigative journalist Emily Le Coz unravels the heart-wrenching narrative of Ashleigh Anderson, a CVS pharmacist whose tragic demise serves as a cautionary tale of overwhelming stress in the workplace. Emily shares her motivations behind delving into the pervasive issue of burnout in retail pharmacy and sheds light on the
